Schmidt WE - Search Results

1

Validation of different replication markers for the detection of beta-cell proliferation in human pancreatic tissue.

Köhler CU, Kreuter A, Rozynkowski MC, Rahmel T, Uhl W, Tannapfel A, Schmidt WE, Meier JJ. Köhler CU, et al. Among authors: schmidt we. Regul Pept. 2010 Jun 8;162(1-3):115-21. doi: 10.1016/j.regpep.2009.12.021. Epub 2010 Jan 14. Regul Pept. 2010. PMID: 20079379

2

Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis.

Schrader H, Menge BA, Schneider S, Belyaev O, Tannapfel A, Uhl W, Schmidt WE, Meier JJ. Schrader H, et al. Among authors: schmidt we. Gastroenterology. 2009 Feb;136(2):513-22. doi: 10.1053/j.gastro.2008.10.083. Epub 2008 Nov 6. Gastroenterology. 2009. PMID: 19041312

3

Beta-cell development and turnover during prenatal life in humans.

Meier JJ, Köhler CU, Alkhatib B, Sergi C, Junker T, Klein HH, Schmidt WE, Fritsch H. Meier JJ, et al. Among authors: schmidt we. Eur J Endocrinol. 2010 Mar;162(3):559-68. doi: 10.1530/EJE-09-1053. Epub 2009 Dec 18. Eur J Endocrinol. 2010. PMID: 20022941

4

Endogenous hyperinsulinaemia in insulinoma patients is not associated with changes in beta-cell area and turnover in the tumor-adjacent pancreas.

Montemurro C, Köhler CU, Uhl W, Tannapfel A, Schmidt WE, Bonora E, Meier JJ. Montemurro C, et al. Among authors: schmidt we. Regul Pept. 2010 Dec 10;165(2-3):180-5. doi: 10.1016/j.regpep.2010.07.164. Epub 2010 Jul 27. Regul Pept. 2010. PMID: 20673781

5

Cell cycle control of β-cell replication in the prenatal and postnatal human pancreas.

Köhler CU, Olewinski M, Tannapfel A, Schmidt WE, Fritsch H, Meier JJ. Köhler CU, et al. Among authors: schmidt we. Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E221-30. doi: 10.1152/ajpendo.00496.2010. Epub 2010 Oct 26. Am J Physiol Endocrinol Metab. 2011. PMID: 20978233 Free article.

6

Impact of proton pump inhibitor treatment on pancreatic beta-cell area and beta-cell proliferation in humans.

Breuer TG, Borker L, Quast DR, Tannapfel A, Schmidt WE, Uhl W, Meier JJ. Breuer TG, et al. Among authors: schmidt we. Eur J Endocrinol. 2016 Nov;175(5):467-76. doi: 10.1530/EJE-16-0320. Epub 2016 Aug 25. Eur J Endocrinol. 2016. PMID: 27562401

7

Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies.

Ueberberg S, Jütte H, Uhl W, Schmidt W, Nauck M, Montanya E, Tannapfel A, Meier J. Ueberberg S, et al. Diabetes Obes Metab. 2016 Dec;18(12):1253-1262. doi: 10.1111/dom.12766. Epub 2016 Sep 26. Diabetes Obes Metab. 2016. PMID: 27545110

8

The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).

Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, Nauck MA. Meier JJ, et al. Among authors: schmidt we. Regul Pept. 2003 May 15;113(1-3):95-100. doi: 10.1016/s0167-0115(02)00297-5. Regul Pept. 2003. PMID: 12686467 Clinical Trial.

9

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.

Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ. Nauck MA, et al. Among authors: schmidt we. Regul Pept. 2004 Nov 15;122(3):209-17. doi: 10.1016/j.regpep.2004.06.020. Regul Pept. 2004. PMID: 15491793

10

Glucagon-like peptide 2 inhibits ghrelin secretion in humans.

Banasch M, Bulut K, Hagemann D, Schrader H, Holst JJ, Schmidt WE, Meier JJ. Banasch M, et al. Among authors: schmidt we. Regul Pept. 2006 Dec 10;137(3):173-8. doi: 10.1016/j.regpep.2006.07.009. Epub 2006 Aug 22. Regul Pept. 2006. PMID: 16928403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page